73P Efficacy Outcomes in ≥70-Year-old or Younger Patients Receiving Regorafenib-to-trifluridine/tipiracil Sequence or Vice Versa for Refractory Metastatic Colorectal Cancer: Findings from the Multicenter Retrospective “retrita” Study
Annals of Oncology(2024)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要